Table 3. Adjusted hazard ratios and 95% confidence intervals for hospitalisation for COVID-19, by comorbidities and individual socioeconomic status, Catalonia, Spain, 30 April 2020.
| Characteristics | Adjusted hazard ratio | Lower 0.95 CI | Upper 0.95 CI | p value |
|---|---|---|---|---|
| Hypertension | 1.40 | 0.82 | 2.38 | 0.20 |
| Diabetes | 1.04 | 0.54 | 1.97 | 0.90 |
| Heart failure | 0.83 | 0.33 | 2.09 | 0.70 |
| COPD | 1.17 | 0.57 | 2.40 | 0.60 |
| Chronic renal disease | 1.70 | 0.89 | 3.25 | 0.10 |
| Asthma | 1.42 | 0.69 | 2.90 | 0.30 |
| Dementia | 1.17 | 0.28 | 4.90 | 0.80 |
| Liver cirrhosis | 2.01 | 0.27 | 14.72 | 0.50 |
| Stroke | 1.28 | 0.57 | 2.88 | 0.50 |
| Coronary artery disease | 0.89 | 0.34 | 2.33 | 0.80 |
| Cancer | 1.44 | 0.80 | 2.60 | 0.20 |
| Current smoker | 0.58 | 0.29 | 1.16 | 0.10 |
| Former smoker | 1.23 | 0.68 | 2.19 | 0.48 |
| IS level < 18,000 € | 1.91 | 0.46 | 7.83 | 0.37 |
| IS level 18,001–100,000 € | 1.08 | 0.25 | 4.76 | 0.9 |
| IS level > 100,000 € | 0 | 0 | – | 0.99 |
| CQ/HCQ exposure | 1.46 | 0.91 | 2.34 | 0.10 |
CI: confidence interval; COPD: chronic obstructive pulmonary disease; COVID-19: coronavirus disease; CQ/HCQ: chloroquine/hydroxychloroquine; IS level: individual socioeconomical level.